GENELABS TECHNOLOGIES INC /CA 4
4 · GENELABS TECHNOLOGIES INC /CA · Filed Jan 31, 2005
Insider Transaction Report
Form 4
AHMED MUMTAZ
V.P.Drug Development
Transactions
- Award
Option Grant
2005-01-27$0.88/sh+40,000$35,200→ 60,000 totalExercise: $0.88Exp: 2015-01-27→ common stock (40,000 underlying) - Award
Option Grant
2005-01-27$0.88/sh+20,000$17,600→ 20,000 totalExercise: $0.88Exp: 2015-01-27→ common stock (20,000 underlying)
Footnotes (2)
- [F1]These options become 50% exercisable on June 30, 2005 and the remainder pro rata monthly over the next six months.
- [F2]These options become 25% exercisable one year from grant date and the remainder pro rata monthly over the next three years.